Document:

EX-10.1

 Exhibit 10.1 
 PREFERRED SHARES PURCHASE AGREEMENT 
 between 

DCP HOLDING COMPANY 
 and 
 CINCINNATI FINANCIAL CORPORATION 

Dated as of January 11, 2013 

 The Redeemable Institutional Preferred Shares have not been registered with the Securities and Exchange
Commission or any state securities authority in reliance on exemptions from registration under applicable securities laws. In making the investment decision, Purchaser must rely on its own examination of the terms of the placement, including the
merits and risks involved. The Redeemable Institutional Preferred Shares have not been recommended by any governmental or regulatory authority. 
 The Redeemable Institutional Preferred Shares are subject to restrictions on transferability and resale and may not be transferred or resold except as permitted by the Amendment to the Company’s
Amended and Restated Articles of Incorporation, in the form attached to this Agreement, and under applicable securities laws. An investment in the Redeemable Institutional Preferred Shares involves risk. Purchaser will be required to bear the
financial risks of an investment in the Redeemable Institutional Preferred Shares for an indefinite period of time. 

  
 -i-

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	 ARTICLE I
	 	SALE AND PURCHASE OF SHARES	  	 	1	  
			
	 SECTION 1.01
	 	Issuance, Sale and Purchase of the Redeemable Institutional Preferred Shares	  	 	1	  
	 SECTION 1.02
	 	Closing	  	 	1	  
			
	 ARTICLE II
	 	REPRESENTATIONS AND WARRANTIES OF THE COMPANY	  	 	2	  
			
	 SECTION 2.01
	 	Organization and Good Standing	  	 	2	  
	 SECTION 2.02
	 	Authority and Binding Obligation	  	 	2	  
	 SECTION 2.03
	 	Capitalization	  	 	2	  
	 SECTION 2.04
	 	The Redeemable Institutional Preferred Shares	  	 	3	  
	 SECTION 2.05
	 	No Violation or Default	  	 	3	  
	 SECTION 2.06
	 	No Conflicts	  	 	3	  
	 SECTION 2.07
	 	No Governmental Consents Required	  	 	3	  
	 SECTION 2.08
	 	Financial Statements	  	 	3	  
	 SECTION 2.09
	 	No Material Adverse Effect	  	 	4	  
	 SECTION 2.10
	 	No Other Representations or Warranties	  	 	4	  
			
	 ARTICLE III
	 	REPRESENTATIONS AND WARRANTIES OF THE PURCHASER	  	 	4	  
			
	 SECTION 3.01
	 	Organization and Good Standing	  	 	4	  
	 SECTION 3.02
	 	Authority and Binding Obligation	  	 	4	  
	 SECTION 3.03
	 	No Conflicts	  	 	5	  
	 SECTION 3.04
	 	No Governmental Consents Required	  	 	5	  
	 SECTION 3.05
	 	Purchase Entirely for Own Account	  	 	5	  
	 SECTION 3.06
	 	Accredited Investor	  	 	5	  
	 SECTION 3.07
	 	Investment Experience	  	 	5	  
	 SECTION 3.08
	 	Disclosure of Information	  	 	5	  
			
	 ARTICLE IV
	 	CONDITIONS TO THE OBLIGATIONS OF THE PURCHASER	  	 	6	  
			
	 SECTION 4.01
	 	Stock Certificates	  	 	6	  
	 SECTION 4.02
	 	Amendment	  	 	6	  
	 SECTION 4.03
	 	[Intentionally Omitted]	  	 	6	  
	 SECTION 4.04
	 	Representations and Warranties	  	 	6	  
	 SECTION 4.05
	 	Performance	  	 	6	  
	 SECTION 4.06
	 	Closing Certificates	  	 	6	  

  
 ii 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	 SECTION 4.07
	 	No Actions or Proceedings	  	 	7	  
			
	 ARTICLE V
	 	CONDITIONS TO THE OBLIGATIONS OF THE COMPANY	  	 	7	  
	 SECTION 5.01
	 	[Intentionally Omitted]	  	 	7	  
	 SECTION 5.02
	 	Representations and Warranties	  	 	7	  
	 SECTION 5.03
	 	Performance	  	 	7	  
	 SECTION 5.04
	 	No Actions or Proceedings	  	 	7	  
			
	 ARTICLE VI
	 	INDEMNIFICATION	  	 	8	  
			
	 SECTION 6.01
	 	Survival	  	 	8	  
	 SECTION 6.02
	 	Indemnification of the Purchaser	  	 	8	  
	 SECTION 6.03
	 	Indemnification of the Company	  	 	8	  
	 SECTION 6.04
	 	Exclusive Remedies	  	 	8	  
			
	 ARTICLE VII
	 	MISCELLANEOUS	  	 	9	  
			
	 SECTION 7.01
	 	Exchange for Equivalent Convertible Preferred Shares	  	 	9	  
	 SECTION 7.02
	 	Brokerage	  	 	9	  
	 SECTION 7.03
	 	Expenses	  	 	9	  
	 SECTION 7.04
	 	Notices	  	 	9	  
	 SECTION 7.05
	 	Governing Law	  	 	10	  
	 SECTION 7.06
	 	Entire Agreement	  	 	11	  
	 SECTION 7.07
	 	Assignments and Successors	  	 	11	  
	 SECTION 7.08
	 	Counterparts	  	 	11	  
	 SECTION 7.09
	 	Amendments	  	 	11	  
	 SECTION 7.10
	 	Severability	  	 	11	  
	 SECTION 7.11
	 	Sections Headings; Construction	  	 	11	  
	 SECTION 7.12
	 	No Third-Party Beneficiaries	  	 	11	  
			
	 Exhibit:
	 		  			
			
	 Exhibit A
	 	Amendment to Amended and Restated Articles of Incorporation	  			

  
 iii

 PREFERRED SHARES PURCHASE AGREEMENT 

This PREFERRED SHARES PURCHASE AGREEMENT (this “Agreement”), dated as of January 11, 2013, is made by and between
DCP Holding Company, an Ohio corporation (the “Company”), and Cincinnati Financial Corporation, an Ohio corporation (the “Purchaser”). The Company and the Purchaser are sometimes individually referred to in this
Agreement as a “Party” and collectively as the “Parties.” 
 WHEREAS, the Company
desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, an aggregate of 1,000 shares of the Company’s Redeemable Institutional Preferred Shares – 2013 (A) Series (the “Redeemable
Institutional Preferred Shares”), for an aggregate purchase price of $1,000,000 in accordance with the terms hereof. 

NOW, THEREFORE, in consideration of the premises and the mutual covenants contained in this Agreement and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
 ARTICLE
I 
 SALE AND PURCHASE OF SHARES 
 SECTION 1.01 Issuance, Sale and Purchase of the Redeemable Institutional Preferred Shares. Subject to the terms and conditions of this Agreement, at the Closing, the Company shall issue and
sell to the Purchaser, and the Purchaser shall purchase from the Company, 1,000 shares of the Redeemable Institutional Preferred Shares for the purchase price of $1,000 per Redeemable Institutional Preferred Share, with an aggregate purchase price
of $1,000,000 (the “Purchase Price”). The Redeemable Institutional Preferred Shares shall have the rights, preferences, privileges, restrictions and other terms as set forth in the Amendment to the Company’s Amended and
Restated Articles of Incorporation in the form attached as Exhibit A hereto (the “Amendment”). 

SECTION 1.02 Closing. The closing of the issuance, sale and purchase of the Redeemable Institutional Preferred Shares (the
“Closing”) shall take place at the offices of the Purchaser, at 6200 S. Gilmore Road, Fairfield, Ohio 45014, at 2:00 p.m. Eastern Time on January 11, 2013, or at such other location, date and time as the Parties may agree. The
date on which the Closing will occur is referred to herein as the “Closing Date.” At the Closing, the Company shall issue and deliver to the Purchaser a stock certificate, registered in the name of the Purchaser, representing the
Redeemable Institutional Preferred Shares in exchange for the payment of the Purchase Price by the Purchaser to the Company pursuant to the wire transfer instructions furnished by the Company. 

 ARTICLE II 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 The Company hereby
represents and warrants to the Purchaser as of the Closing Date as follows: 
 SECTION 2.01 Organization and Good
Standing. The Company and its subsidiaries have been duly incorporated or organized and are validly existing and in good standing under the laws of their respective jurisdictions of incorporation or organization, are duly qualified to do
business and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold
their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so qualified, in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse
effect on the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under this Agreement (a “Material Adverse Effect”). 

SECTION 2.02 Authority and Binding Obligation. The Company has the necessary corporate power and authority to
execute and deliver this Agreement and to perform its obligations hereunder. The Company has duly executed and delivered this Agreement and, assuming due authorization, execution and delivery hereof by the Purchaser, this Agreement constitutes the
valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or other similar laws relating to
creditors’ rights and general principles of equity. 
 SECTION 2.03 Capitalization. All issued and
outstanding shares of capital stock of the Company have been duly authorized and validly issued and are fully paid and non-assessable and, except as disclosed in the Company Reports (as defined in Section 2.08), are not subject to any
preemptive rights. Except as disclosed in the Company Reports and set forth in the Amendment, (i) there are no options, warrants, calls, subscriptions, convertible securities or other rights, agreements or commitments which obligate the Company
or any of its subsidiaries to issue, transfer, sell or register any shares of capital stock or other securities of the Company or any of its subsidiaries, (ii) there are no outstanding obligations of the Company or any of its subsidiaries to
repurchase, redeem or otherwise acquire any shares of capital stock of the Company or any of its subsidiaries and (iii) there are no outstanding stock appreciation rights, security-based performance units, “phantom” stock or other
security rights or other agreements or arrangements pursuant to which any person is or may be entitled to receive any payment or other value based on the revenues, earnings or financial performance or other attribute of the Company or any of its
subsidiaries or assets or calculated in accordance therewith (other than payments or commissions to employees or agents of the Company or any of its Subsidiaries in the ordinary course of business consistent with past practices). The Company has no
outstanding bonds, debentures, notes or other obligations the holders of which have the right to vote (or which are convertible into or exercisable for securities having the right to vote) with the shareholders of the Company on any matter. There
are no voting trusts or other agreements or 

  
 - 2 -

 
understandings to which the Company is a party with respect to the voting of capital stock of the Company. 
 SECTION 2.04 The Redeemable Institutional Preferred Shares. The Redeemable Institutional Preferred Shares to be issued and sold by the Company hereunder, when issued and delivered and
paid for as provided herein, will be duly authorized, validly issued, fully paid and nonassessable. The issuance of the Redeemable Institutional Preferred Shares is not subject to any preemptive or similar rights. 

SECTION 2.05 No Violation or Default. Neither the Company nor any of its subsidiaries is: (i) in violation of its
articles of incorporation or code of regulations or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance
of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is
bound or to which any of the property or assets of the Company or any of its subsidiaries is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or
regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect. 

SECTION 2.06 No Conflicts. The execution, delivery and performance by the Company of this Agreement, including the
issuance and sale of the Redeemable Institutional Preferred Shares, will not: (i) result in any violation of the provisions of the articles of incorporation or code of regulations or similar organizational documents of the Company or any of its
subsidiaries, (ii) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of
the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries
is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or
governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such conflict, breach, violation or default that would not, individually or in the aggregate, have a Material Adverse Effect. 

SECTION 2.07 No Governmental Consents Required. Subject, in part, to the truth and accuracy of the Purchaser’s
representations set forth in Article III, no consent, approval, authorization, order, license, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required to be obtained or made by the Company
for the execution, delivery and performance by the Company of this Agreement, including the issuance and sale of the Redeemable Institutional Preferred Shares. 
 SECTION 2.08 Financial Statements. The financial statements (including the related notes thereto) of the Company and its consolidated subsidiaries included or incorporated by reference in
the reports filed by the Company with the U.S. Securities and Exchange 

  
 - 3 -

 
Commission (the “SEC”) since December 31, 2011 (including exhibits and any amendments thereto or incorporated by reference therein, the “Company Reports”)
comply in all material respects with the applicable requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended, as applicable, and fairly present in all
material respects the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified (subject, in the case of unaudited
statements, to (i) such exceptions as may be permitted for quarterly reports on Form 10-Q filed with the SEC and (ii) normal, recurring year-end audit adjustments which are not material in the aggregate). Such financial statements
have been prepared in conformity with generally accepted accounting principles in the United States applied on a consistent basis throughout the periods covered thereby, except as may be noted therein. 

SECTION 2.09 No Material Adverse Effect. Since the date of the most recent financial statements of the Company included or
incorporated by reference in the Company Reports (i) there has not been any Material Adverse Effect and (ii) except for actions taken in connection with this Agreement or the transactions contemplated hereby, the Company and its
subsidiaries have conducted their respective businesses in the ordinary course. 
 SECTION 2.10 No Other Representations
or Warranties. Except for the representations and warranties made by the Company in this Article II, neither the Company nor any other person makes any representation or warranty with respect to the Company or its subsidiaries or their
respective businesses, operations, assets, liabilities, condition (financial or otherwise) or prospects, notwithstanding the delivery or disclosure to the Purchaser or any of its affiliates or representatives of any documentation, forecasts or other
information with respect to any one or more of the foregoing. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF THE PURCHASER 
 The Purchaser represents and warrants to the Company as of the Closing Date as follows: 
 SECTION 3.01 Organization and Good Standing. The Purchaser has been duly incorporated or organized and is validly existing and in good standing under the laws of its jurisdiction of
incorporation or organization, is duly qualified to do business and is in good standing in each jurisdiction in which its ownership or lease of property or the conduct of its business requires such qualification, and has all power and authority
necessary to own or hold its properties and to conduct the businesses in which it is engaged, except where the failure to be so qualified, in good standing or have such power or authority would not, individually or in the aggregate, have a material
adverse effect on the Purchaser or on the performance by the Purchaser of its obligations under this Agreement (a “Purchaser Material Adverse Effect”). 
 SECTION 3.02 Authority and Binding Obligations. The Purchaser has the necessary corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder.
The Purchaser has duly executed and delivered this Agreement and, assuming due authorization, execution and delivery hereof by the Company, this Agreement 

  
 - 4 -

 
constitutes the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium or other similar laws relating to creditors’ rights and general principles of equity. 

SECTION 3.03 No Conflicts. The execution, delivery and performance by the Purchaser of
this Agreement, including the purchase of the Redeemable Institutional Preferred Shares, will not (i) result in any violation of the provisions of the articles of incorporation or code of regulations or similar organizational documents of the
Purchaser, (ii) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the
Purchaser pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Purchaser is a party or by which it is bound or to which any of its properties or assets is subject, or (iii) result in
the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such conflict, breach,
violation or default that would not, individually or in the aggregate, have a Purchaser Material Adverse Effect. 

SECTION 3.04 No Governmental Consents Required. No consent, approval, authorization, order, license, registration or
qualification of or with any court or arbitrator or governmental or regulatory authority is required to be obtained or made by the Purchaser for the execution, delivery and performance by the Purchaser of this Agreement. 

SECTION 3.05 Purchase Entirely for Own Account. The Purchaser is acquiring the Redeemable Institutional Preferred
Shares for its own account for the purpose of investment only, without any view toward sale or distribution. 
 SECTION 3.06
Accredited Investor. The Purchaser is an “accredited investor” within the meaning of Rule 501 promulgated under the Securities Act. 
 SECTION 3.07 Investment Experience. The Purchaser has such knowledge and experience in financial and business matters so as to be able to evaluate the risks and merits of its investment in
the Company and it is able financially to bear the risks thereof. 
 SECTION 3.08 Disclosure of Information. The
Purchaser has reviewed the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011 and the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2012; has had an opportunity
to discuss the Company’s business, management and financial affairs with the Company’s management and has had all of Purchaser’s questions regarding the Company or the Redeemable Institutional Preferred Shares answered to
Purchaser’s satisfaction. The Purchaser understands that (i) the Redeemable Institutional Preferred Shares have not been registered under the Securities Act or any state securities or blue sky laws by reason of their issuance in a
transaction exempt from the registration requirements of the Securities Act, (ii) no public agency has reviewed the accuracy or adequacy of any information furnished to the Purchaser and the Purchaser’s representatives in connection with
the Purchaser’s purchase of the Redeemable Institutional Preferred Shares, (iii) there will be no public market for the 

  
 - 5 -

 
Redeemable Institutional Preferred Shares and the Redeemable Institutional Preferred Shares will not be readily salable, (iv) the Redeemable Institutional Preferred Shares will be subject to
restrictions on transfer under the Amendment and the Company’s Amended and Restated Code of Regulations, and (v) even if the Redeemable Institutional Preferred Shares are subsequently registered or qualified under the Securities Act and
registered or qualified under state securities or blue sky laws, or an exemption from such registration and qualification is available, the amount or percentage of the Redeemable Institutional Preferred Shares that may be sold or transferred may be
limited by applicable federal and state laws, rules and regulations. The Purchaser is not relying upon any representation or warranty of any employee, officer or director of the Company other than as provided herein. 

ARTICLE IV 

CONDITIONS TO THE OBLIGATIONS OF THE PURCHASER 
 The obligations of the Purchaser to purchase and pay for the Redeemable Institutional Preferred Shares at the Closing are subject to the satisfaction, at or prior to the Closing, of the following
conditions (any of which may be waived by the Purchaser, in whole or in part): 
 SECTION 4.01 Stock Certificates.
The Purchaser shall have received a certificate representing the Redeemable Institutional Preferred Shares. 
 SECTION 4.02
Amendment. The Amendment shall have been duly filed with and accepted by the Secretary of State of the State of Ohio. 
 SECTION 4.03 [Intentionally Omitted]. 
 SECTION 4.04
Representations and Warranties. The representations and warranties contained in Article II shall be true and correct in all material respects, and an executive officer of the Company shall have certified to such effect to the Purchaser in
writing. 
 SECTION 4.05 Performance. The Company shall have performed and complied in all material respects with
all agreements contained herein required to be performed or complied with by it at or prior to the Closing and an executive officer of the Company shall have certified to the Purchaser in writing to such effect. 

SECTION 4.06 Closing Certificates. The Purchaser shall have received copies of the following certificates and other
documents: 
 (a) the Amendment, certified by the Secretary of State of the State of Ohio; 

(b) a certificate of the Secretary of State of the State of Ohio, dated as of a recent date, as to the good standing of the Company; and

 (c) a certificate of the Secretary of the Company dated the Closing Date and certifying: 

  
 - 6 -

 (i) that attached thereto is a true and complete copy of the Amended and
Restated Code of Regulations of the Company as in effect on the date of such certification; and 
 (ii) that
attached thereto is a true and complete copy of all resolutions of the Board of Directors of the Company adopting the Amendment and authorizing the execution, delivery and performance of this Agreement, including the issuance and sale of the
Redeemable Institutional Preferred Shares, and that all such resolutions are in full force and effect. 
 SECTION 4.07 No
Actions or Proceedings. No action or proceeding by or before any court, administrative body or governmental agency shall have been instituted or threatened which seeks to enjoin, restrain or prohibit this Agreement or the consummation of the
transactions contemplated by this Agreement. No law or regulation shall be in effect and no court order shall have been entered in any action or proceeding instituted by any party which enjoins, restrains or prohibits this Agreement or the
consummation of the transactions contemplated by this Agreement. 
 ARTICLE V 

CONDITIONS TO THE OBLIGATIONS OF THE COMPANY 
 The obligations of the Company to issue and sell the Redeemable Institutional Preferred Shares at the Closing are subject to the satisfaction, at or prior to the Closing, of the following conditions (any
of which may be waived by the Company, in whole or in part): 
 SECTION 5.01 [Intentionally Omitted]. 

SECTION 5.02 Representations and Warranties. The representations and warranties contained in Article III shall be true and
correct in all material respects, and an executive officer of the Purchaser shall have certified to such effect to the Company in writing. 
 SECTION 5.03 Performance. The Purchaser shall have performed and complied in all material respects with all agreements contained herein required to be performed or complied with by it at or
prior to the Closing and an executive officer of the Purchaser shall have certified to the Company in writing to such effect. 

SECTION 5.04 No Actions or Proceedings. No action or proceeding by or before any court, administrative body or governmental
agency shall have been instituted or threatened which seeks to enjoin, restrain or prohibit this Agreement or the consummation of the transactions contemplated by this Agreement. No law or regulation shall be in effect and no court order shall have
been entered in any action or proceeding instituted by any party which enjoins, restrains or prohibits this Agreement or the consummation of the transactions contemplated by this Agreement. 

  
 - 7 -

 ARTICLE VI 
 INDEMNIFICATION 
 SECTION 6.01 Survival. All covenants,
agreements, representations and warranties made by either Party in this Agreement, and the indemnification obligations of the Parties with respect thereto, shall survive the execution and delivery of this Agreement and the Closing and continue in
full force and effect until the one-year anniversary of the Closing Date (the “Termination Date”). If, at any time prior to the Termination Date, any Purchaser Indemnified Party or Company Indemnified Party (as such terms are
defined in Sections 6.02 and 6.03), as the case may be, delivers to the other Party a written notice asserting a claim for indemnification hereunder, then the claim asserted in such written notice shall survive until such time as such claim is
finally resolved. 
 SECTION 6.02 Indemnification of the Purchaser. The Company shall indemnify and hold harmless
the Purchaser and each affiliate, shareholder, director, officer, employee, agent, representative and successor in interest of the Purchaser (the “Purchaser Indemnified Parties”) from and against any and all losses, liabilities,
damages, demands, claims, suits, actions, judgments or causes of action, assessments, costs and expenses, including interest, penalties, reasonable attorneys’ fees, any and all reasonable expenses incurred in investigating, preparing or
defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation (collectively, “Damages”) asserted against, resulting to, imposed upon, or
incurred or suffered by the Purchaser Indemnified Parties, directly or indirectly, as a result of or arising from (i) any inaccuracy in or breach of any of the representations and warranties made by the Company in this Agreement or
(ii) any breach of or nonperformance by the Company of its covenants, agreements or other obligations under this Agreement. 
 SECTION 6.03 Indemnification of the Company. The Purchaser shall indemnify and hold harmless the Company and each affiliate, shareholder, director, officer, employee, agent, representative
and successor in interest of the Company (the “Company Indemnified Parties”) from and against any and all Damages, asserted against, resulting to, imposed upon, or incurred or suffered by the Company Indemnified Parties, directly or
indirectly, as a result of or arising from (i) any inaccuracy in or breach of any of the representations and warranties made by the Purchaser in this Agreement or (ii) any breach of or nonperformance by the Purchaser of its covenants,
agreements or other obligations under this Agreement. 
 SECTION 6.04 Exclusive Remedies. The remedies provided in
this Article VI shall be deemed the sole and exclusive remedies of the Parties with respect to this Agreement and the transactions contemplated hereby after the Closing, and no Party shall pursue or seek to pursue any other remedy except for any
equitable relief to which any Party may be entitled or in the case of fraud. 

  
 - 8 -

 ARTICLE VII 
 MISCELLANEOUS 
 SECTION 7.01 Exchange for Equivalent Convertible
Preferred Shares. The Parties acknowledge that the Company has under active consideration a revision to its Amended and Restated Articles of Incorporation that would allow the issuance of Preferred Shares that would be convertible into a
class of Common Shares. In the event that: (i) the Company’s Board of Directors and the holders of the Class A Common Shares approve the necessary amendment(s) to the Company’s Amended and Restated Articles of Incorporation
and/or its Amended and Restated Code of Regulations to provide the Company with the authority to issue one or more series of Preferred Shares that are convertible, at the option of the holders thereof, into any class of Common Shares; (ii) the
Company’s Board of Directors subsequently fixes the terms of such convertible Preferred Shares (the “Convertible Preferred Shares”) so that such terms include (A) an annual dividend that is equivalent to the annual
dividend on the Redeemable Institutional Preferred Shares, as described in the Amendment, (B) a put right for the holders of the Convertible Preferred Shares that is equivalent to the put right of the holders of the Redeemable Institutional
Preferred Shares, as described in the Amendment, (C) a conversion ratio in respect of the conversion of Convertible Preferred Shares into Common Shares that is substantially equivalent to the Conversion Ratio, as defined in the Amendment, and
(D) terms that are otherwise no less favorable in any material respect to holders of the Redeemable Institutional Preferred Shares than those contained in the Amendment; and (iii) the Company offers to exchange such number of Convertible
Preferred Shares for all then-outstanding Redeemable Institutional Preferred Shares so that, upon consummation of such exchange, the prior holders of the Redeemable Institutional Preferred Shares will hold Convertible Preferred Shares representing
the same percentage of the outstanding capital stock of the Company as such holders held immediately prior to the consummation of such exchange, then the Purchaser (and any assignee or transferee) of the Redeemable Institutional Preferred Shares
shall be obligated to exchange its Redeemable Institutional Preferred Shares for such Convertible Preferred Shares. The Parties agree that nothing in this Section 7.01 shall be construed or interpreted as creating any binding obligation or
covenant of the Company or limiting, restricting or modifying the discretion, obligations or duties of the Company’s Board of Directors. Capitalized terms used in this Section 7.01 but not defined in this Agreement shall have the meanings
given such terms in the Company’s Amended and Restated Articles of Incorporation. 
 SECTION 7.02 Brokerage.
Each Party hereto will indemnify and hold harmless the other against and in respect of any claim for brokerage or other commissions relative to this Agreement or to the transactions contemplated hereby, based in any way on agreements, arrangements
or understandings made or claimed to have been made by such Party with any third party. 
 SECTION 7.03 Expenses.
Each Party shall pay all of its own fees and expenses incurred in connection with the negotiation, preparation and execution of this Agreement. 
 SECTION 7.04 Notices. All notices, requests, consents and other communications hereunder shall be in writing and will be deemed to have been duly given when (i) delivered by hand (with
written confirmation of receipt), (ii) received by the addressee, if sent by a nationally 

  
 - 9 -

 
recognized overnight delivery service, (iii) received by the addressee, if mailed by certified or registered mail, return receipt requested, or (iv) sent by telecopier or email (with
confirmation of receipt), addressed as follows: 
 If to the Company: 
 DCP Holding Company 
 100 Crowne Point Place 

Sharonville, OH 45241 
 Attention: Robert C. Hodgkins, Jr., Vice President and Chief Financial Officer 

Facsimile: (513) 554-3187 
 E mail: rhodgkins@dentalcareplus.com 
 With a copy to: 

Baker & Hostetler LLP 
 312 Walnut Street 
 Suite 3200 

Cincinnati, OH 45202 
 Attention: Thomas W. Kahle 
 Facsimile: (513) 929-0303 

E mail: tkahle@bakerlaw.com 
 If
to the Purchaser: 
 Cincinnati Financial Corporation 
 6200 S. Gilmore Road 
 Fairfield, OH 45014 

Attention: Michael Abrams 
 Facsimile: (        )          -         

E mail: Michael_Abrams@CINFIN.com 
  

					
	With a copy to:	  	
			
		  	  
	  	
		  	  
	  	
		  	  
	  	
		  	Attention:                            
                                         
            	  	
		  	Facsimile: (        
)                                 
-                                	  	
		  	E
mail:                                        
                                         
    	  	

 or, in any such case, at such other address or addresses as shall have been furnished in writing by such Party to the
other. 
 SECTION 7.05 Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of Ohio. 

  
 - 10 -

 SECTION 7.06 Entire Agreement. This Agreement, including the Schedules and
Exhibits hereto, supersedes all prior agreements between the Parties with respect to its subject matter and constitutes the sole and entire agreement of the Parties with respect to the subject matter hereof. All Schedules and Exhibits hereto are
hereby incorporated herein by reference. 
 SECTION 7.07 Assignments and Successors. This Agreement shall not be
assigned by either of the Parties (whether by operation of law or otherwise) without the prior written consent of the other party. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by
the Parties and their respective successors and assigns. 
 SECTION 7.08 Counterparts. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 SECTION 7.09 Amendments. This Agreement may be amended or modified with the written consent of the Company and the Purchaser. 

SECTION 7.10 Severability. If any provision of this Agreement shall be declared void or unenforceable by any judicial or
administrative authority, the validity of any other provision and of the entire Agreement shall not be affected thereby. 

SECTION 7.11 Section Headings; Construction. The headings of Articles and Sections in this Agreement are for convenience
only and are not to be considered in construing or interpreting any term or provision of this Agreement. All references to “Article”, “Articles”, “Section” or “Sections” refer to the corresponding Article,
Articles, Section or Sections (or sub-Section or sub-Sections) of this Agreement. All words used in this Agreement will be construed to be of such gender or number as the circumstances require. Unless otherwise expressly provided, the word
“including” does not limit the preceding words or terms. 
 SECTION 7.12 No Third-Party Beneficiaries.
This Agreement shall not confer any rights or remedies upon any person other than the Parties and their respective successors and permitted assigns, except for the rights of the Purchaser Indemnified Parties and Company Indemnified Parties under
Article VI of this Agreement. 
 [Signatures of the Parties intentionally appear on the next page.] 

  
 - 11 -

 IN WITNESS WHEREOF, the undersigned have executed this Preferred Shares Purchase Agreement
as of the date first set forth above. 
  

			
	THE COMPANY:
	
	DCP HOLDING COMPANY
		
	By:	 	/s/ Anthony A. Cook
		 	  

	Name:	 	Anthony A. Cook
	Title:	 	President and Chief Executive Officer
	
	THE PURCHASER:
	
	CINCINNATI FINANCIAL CORPORATION
		
	By:	 	/s/ Martin F. Hollenbeck, CFA
		 	  

	Name:	 	Martin F. Hollenbeck
	Title:	 	SVP & Chief Investment Officer

  
 - 12 -

 Exhibit A 

Amendment to Amended and Restated Articles of Incorporation 

(attached) 

 Certificate 
 of 
 Amendment 

to 

Amended and Restated Articles of Incorporation 
 of 
 DCP Holding Company 

The following amendment to the Amended and Restated Articles of Incorporation of DCP Holding Company (the “Corporation”),
adopted in accordance with Article FOURTH, Section B.1. of the Amended and Restated Articles of Incorporation, was adopted by the Board of Directors on December 12, 2012, at a meeting of the Board of Directors on that date pursuant to the
authority of Section 1701.70(B) and 1701.73(A) and (C) of the Ohio Revised Code. 
 RESOLVED, that, pursuant to
authority expressly vested in the Board of Directors of the Corporation by the provisions of the Amended and Restated Articles of Incorporation of the Corporation, the Board of Directors of the Corporation duly adopted the following amendment to the
Amended and Restated Articles of Incorporation of the Corporation; and 
 FURTHER RESOLVED, that the Amended and Restated
Articles of Incorporation of the Corporation be, and hereby are, amended by adding at the end of Section B of Article FOURTH a new subsection 9 that reads as follows: 
 9. THE REDEEMABLE INSTITUTIONAL PREFERRED SHARES – 2013 (A) SERIES 
 The
Redeemable Institutional Preferred Shares – 2013 (A) Series shall have the following express terms: 
 (a) DESIGNATION,
AMOUNT AND SERIES. Of the 100,000 authorized Preferred Shares, 1,000 are designated as the “Redeemable Institutional Preferred Shares – 2013 (A) Series” (the “2013A Redeemable Institutional Preferred Shares”). The 2013A
Redeemable Institutional Preferred Shares have the express terms set forth in this Section B of Article FOURTH as being applicable to all Preferred Shares as a class and, in addition, the following express terms. 

(b) ELIGIBLE OWNER. Only an “accredited investor” (within the meaning of Rule 501 promulgated under the Securities Act of 1933,
as amended), which is not an insurance company, dental HMO, dental PPO, a company that offers and sells a vision benefit product, an affiliate of any of the foregoing, or any person or entity acting directly or indirectly on behalf of any of the
foregoing or affiliate thereof, is eligible to purchase, own or hold the 2013A Redeemable Institutional Preferred Shares (a “2013A Redeemable Institutional Preferred Eligible Owner”). 

 (c) CONSIDERATION FOR ISSUANCE. The per share purchase price for the 2013A Redeemable
Institutional Preferred Shares will be $1,000 (hereinafter referred to in this subsection 9 as the “2013A Issue Price”). 
 (d) DIVIDENDS. 
 (i) Each 2013A Redeemable Institutional
Preferred Share will carry an annual dividend at a rate equal to: (A) in respect of the dividend for 2013, 5% of the per share 2013A Issue Price, prorated based on the number of days that the 2013A Redeemable Institutional Preferred Share was
outstanding in 2013, payable in four equal quarterly installments on or before the last business day of each calendar quarter of 2013; and (B) in respect of the dividends for 2014 and all years thereafter, 5% of the Adjusted Book Value per
2013A Redeemable Institutional Preferred Share (as defined below) as of December 31 of the preceding year. The dividend on the 2013A Redeemable Institutional Preferred Shares for 2014 and all years thereafter, once declared by the
Corporation’s Board of Directors, shall be paid by the Corporation in four equal quarterly installments, on or before the last business day of the calendar quarter of the year for which the dividend was declared, to each holder of a 2013A
Redeemable Institutional Preferred Share who was a record holder of such share on December 31 of the prior calendar year. (For example, the annual dividend for 2014 will be 5% of the Adjusted Book Value per 2013A Redeemable Institutional
Preferred Share as of December 31, 2013 and will be paid in four equal installments on or before the last business day of each calendar quarter of 2014.) In the event that a 2013A Redeemable Institutional Preferred Share is not outstanding for
the entire year in which the dividend is paid, the dividend payable during such quarter shall be proportionately reduced based on the number of days in the quarter the 2013A Redeemable Institutional Preferred Share was outstanding. Following the
payment of a dividend on the 2013A Redeemable Institutional Preferred Shares for any calendar year, any subsequent payment of a dividend on the 2013A Redeemable Institutional Preferred Shares, including in connection with a Liquidation Event (as
defined in subsection (h) of this subsection 9 below) or the exercise of a Put Right or Call Right (as defined in subsection (g) of this subsection 9 below), shall include any adjustments necessary to reconcile estimated and actual
calculations of Adjusted Book Value per 2013A Redeemable Institutional Preferred Share as of December 31 of the calendar year for which the dividend on the 2013A Redeemable Institutional Preferred Shares was paid based upon the year-end audit
of the Corporation’s financial statements. The dividend on the 2013A Redeemable Institutional Preferred Shares, if not declared payable by the Corporation’s Board of Directors or otherwise not paid for any reason, shall cumulate and
compound annually. 
 (ii) For purposes of this subsection 9, the “Adjusted Book Value per 2013A Redeemable Institutional
Preferred Share” shall be an amount determined in accordance with generally accepted accounting principles and the following: 
 (A) As of the end of each calendar month after January 2013, the book value of the Preferred Shares (as defined in the first paragraph of this Article FOURTH), including the 2013A Redeemable Institutional
Preferred Shares, the 2012A Redeemable Institutional Preferred Shares (as defined in subsection 8(a) of Section B of this Article FOURTH), the Redeemable Institutional Preferred Shares – 2010 (A) Series (as described in subsection 7 of
Section B of this Article FOURTH, hereinafter referred to in this 

  
 - 2 -

 
subsection 9 as the “2010 Redeemable Institutional Preferred Shares”) and the Provider Preferred Shares (as defined in subsection 6(a) of Section B of this Article FOURTH), the
Class A Common Shares (as defined in the first paragraph of this Article FOURTH), and the Class B Common Shares (as defined in the first paragraph of this Article FOURTH; the Class A Common Shares, Class B Common Shares and any additional
class of common shares that may be issued by the Corporation in the future, collectively, are hereinafter referred to in this subsection 9 as the “Common Shares”), shall be adjusted as follows: 

first, net earnings or net losses of the Corporation (constituting net income or loss plus other comprehensive income or loss) for
the completed monthly period will be reduced by the amount of the dividends accrued during the completed monthly period on the 2010 Redeemable Institutional Preferred Shares, the 2012A Redeemable Institutional Preferred Shares and the 2013A
Redeemable Institutional Preferred Shares; and 
 thereafter, the net earnings or net losses of the Corporation from the
completed monthly period, as adjusted pursuant to the preceding paragraph, will be allocated among the Preferred Shares, including the 2013A Redeemable Institutional Preferred Shares, the 2012A Redeemable Institutional Preferred Shares, the 2010
Redeemable Institutional Preferred Shares and the Provider Preferred Shares, and the Common Shares based upon their respective and relative percentages of the total equity of the Corporation, based upon 50% of the aggregate book value of the 2013A
Redeemable Institutional Preferred Shares, 50% of the aggregate book value of the 2012A Redeemable Institutional Preferred Shares, 50% of the aggregate book value of the 2010 Redeemable Institutional Preferred Shares and 100% of the aggregate book
value of the Provider Preferred Shares, and based on a percentage of the aggregate book value of shares of other series of Preferred Shares to be determined subject to the terms of any such series of Preferred Shares as may be fixed by the Board of
Directors, and 100% of the aggregate book value of the Common Shares, in each case as of the month end date immediately preceding the monthly period in question. 
 (B) After the allocation of net earnings or net losses to the Preferred Shares, including the 2013A Redeemable Institutional Preferred Shares, the 2012A Redeemable Institutional Preferred Shares, the 2010
Redeemable Institutional Preferred Shares and the Provider Preferred Shares, and Common Shares pursuant to the paragraphs under subsection (A) above, the aggregate book value of the Preferred Shares, including the 2013A Redeemable Institutional
Preferred Shares, the 2012A Redeemable Institutional Preferred Shares, the 2010 Redeemable Institutional Preferred Shares and the Provider Preferred Shares, and Common Shares will be adjusted for any purchases or redemptions (including in connection
with the exercise of a Put Right or Call Right pursuant to subsection 9(g) or similar right pursuant to subsections 6(g), 7(g) and 8(g) of Section B of this Article Fourth) thereof during the completed monthly period. 

(C) The adjusted aggregate book values of the Preferred Shares, including the 2013A Redeemable Institutional Preferred Shares, the 2012A
Redeemable Institutional Preferred Shares, the 2010 Redeemable Institutional Preferred Shares and the Provider Preferred Shares, and Common Shares as described in this subsection (d)(ii) will be used as the basis of the allocation of the net
earnings or net losses of the Corporation in the 

  
 - 3 -

 
following monthly period and will be subject to any adjustments necessary to reconcile estimated and actual calculations of Adjusted Book Value per 2013A Redeemable Institutional Preferred Share
based upon the year-end audit of the Corporation’s financial statements. 
 (e) NO VOTING RIGHTS; PROTECTIVE PROVISIONS.

 (i) Except as provided in subsection (ii) below or as required by law, the 2013A Redeemable Institutional Preferred
Shares shall have no voting rights. 
 (ii) So long as any 2013A Redeemable Institutional Preferred Shares are outstanding, the
Corporation may not, without the consent of the holders of at least two-thirds of the 2013A Redeemable Institutional Preferred Shares, by amendment, merger, consolidation or otherwise, purchase or redeem or pay any dividend on any capital stock of
the Corporation prior to the 2013A Redeemable Institutional Preferred Shares, other than (A) Common Shares repurchased from former directors or employees in connection with the cessation of their services or employment at a price not greater
than book value as of the month-end immediately preceding their termination date, (B) shares of the Corporation’s capital stock repurchased pursuant to the Corporation’s Amended and Restated Code of Regulations, (C) 2012A
Redeemable Institutional Preferred Shares redeemed or repurchased pursuant to subsection 8(f) of Section B of this Article FOURTH, (D) 2010 Redeemable Institutional Preferred Shares redeemed or repurchased pursuant to subsection 7(f) or 7(g) of
Section B of this Article FOURTH, (E) Provider Preferred Shares redeemed or repurchased pursuant to subsection 6(f) or 6(g) of Section B of this Article FOURTH and (F) redemptions of other Preferred Shares that may be issued in the future
pursuant to the terms thereof as fixed by the Board of Directors. For the avoidance of doubt, “capital stock” as used in this subsection shall not include restricted share units, phantom shares or other derivate securities of the
Corporation. 
 (f) RESTRICTIONS ON TRANSFER. 
 (i) No transfers. Except as specifically provided in this subsection (f), no legal or beneficial holder of 2013A Redeemable Institutional Preferred Shares may transfer, gift, sell or assign any
2013A Redeemable Institutional Preferred Shares or interests therein, legal or equitable, whether now owned or hereafter acquired, or authorize, permit or suffer any such transfer, gift, sale or assignment. Any attempted transfer, gift, sale or
assignment of 2013A Redeemable Institutional Preferred Shares or any interest therein not in compliance with this subsection (f) will be null and void ab initio as against the Corporation and all other persons, including but not limited
to the transferor and transferee. Without limiting the generality of the foregoing, no transfer, gift, sale or assignment will be permitted or recognized, even if permitted by any other provision of this subsection (f), unless each of the following
conditions is satisfied in the judgment of, or waived in writing by, the Board of Directors in its discretion: (A) the transferor complies with all of the applicable provisions of this subsection (f); (B) the transferor and transferee each
execute, acknowledge and deliver to the Corporation such instruments of transfer, assignment and assumption with respect to such transfer and such other instruments, acknowledgements and documents as may be reasonably deemed necessary by, and in
form and substance reasonably satisfactory to, the Corporation to establish or evidence compliance with the provisions of this subsection (f); (C) the Corporation shall have received, at the expense of

  
 - 4 -

 
the parties to the transfer, an opinion of counsel of the Corporation (or other counsel acceptable to counsel of the Corporation) to the effect that such transfer is exempt from registration
under the Securities Act of 1933, as amended, and is in compliance with all applicable federal and state securities laws and regulations; provided, however, the Board of Directors, in its sole discretion, may waive such opinion requirement; and
(D) the transfer does not cause any breach or violation of, cause an event of default under, or result in acceleration of maturity of any indebtedness or other obligations under, any contract, note, mortgage, loan or other instrument or
document to which the Corporation or any of its subsidiaries is a party or by which any of its or their assets or properties is bound. 
 (ii) Permitted Transfers to Certain Purchasers and Corporation’s Right of First Refusal. If a holder of 2013A Redeemable Institutional Preferred Shares desires to accept a bona fide offer in
writing from a 2013A Redeemable Institutional Preferred Eligible Owner (a “Proposed Transferee” for purposes of this subsection) for the purchase of all (but not less than all) of the 2013A Redeemable Institutional Preferred Shares owned
by such holder (hereinafter referred to in this subsection as the “Offered Shares”), such holder shall promptly deliver to the Corporation a written offer (hereinafter referred to in this subsection as an “Offer”) to sell the
Offered Shares to the Corporation for a purchase price not more than the purchase price offered by the Proposed Transferee and on such other terms and conditions that, taken as a whole, are no less favorable to the Corporation than those set forth
in the offer from the Proposed Transferee. The Offer shall disclose the identity of the Proposed Transferee, the terms of the bona fide offer from the Proposed Transferee (including the date on which the transfer of the Offered Shares will be
abandoned and terminated if not then consummated (the “Termination Date” for purposes of this subsection)), any other material facts relating to the proposed transfer and proof that the Proposed Transferee is a 2013A Redeemable
Institutional Preferred Eligible Owner. Within 15 days after receipt of the Offer, the Corporation may give written notice to such holder of the Corporation’s intent to purchase all of the Offered Shares within 30 days of such notice given by
the Corporation on substantially the same terms and conditions as set forth in the Offer. If the Corporation does not exercise its purchase right under this subsection (f)(ii), upon the approval of the Board of Directors, which shall not be
unreasonably withheld so long as (A) the Proposed Transferee is a 2013A Redeemable Institutional Preferred Eligible Owner and (B) the requirements for transfer set forth in subsection (f)(i) above are satisfied or waived by the Board of
Directors, the holder may thereafter transfer all (but not less than all) of the Offered Shares to the Proposed Transferee for a purchase price not less than the purchase price set forth in the Offer and upon such other terms and conditions that,
taken as a whole, are no more favorable to the Proposed Transferee than those set forth in the Offer; provided that the transfer must be consummated or abandoned and terminated by the earlier of the Termination Date and the date that is 10 days
after the Board of Directors approves such transfer. 
 (g) PUT AND CALL RIGHTS. 

(i) A holder of the 2013A Redeemable Institutional Preferred Shares shall have the right (referred to in this subsection 9 as the
“Put Right”), exercisable upon written notice to the Corporation (hereinafter referred to in this subsection (g) as a “Put Notice”), to require the Corporation to redeem all or any portion of the 2013A Redeemable
Institutional Preferred Shares held by such holder on the terms set forth in this subsection (g). 

  
 - 5 -

 (ii) The Corporation shall have the right (referred to in this subsection 9 as the
“Call Right”), exercisable upon written notice to a holder of 2013A Redeemable Institutional Preferred Shares (hereinafter referred to in this subsection (g) as a “Call Notice”), to redeem from such holder all or any portion
of the 2013A Redeemable Institutional Preferred Shares held by such holder on the terms set forth in this subsection (g). 

(iii) Within 180 days after the Corporation’s receipt of a Put Notice or a holder’s receipt of a Call Notice, as the case may
be, and, in the case of the exercise by the Corporation of the Call Right, no earlier than 30 days after a holder’s receipt of a Call Notice, the Corporation shall repurchase from the holder, and such holder shall sell and deliver to the
Corporation, the number of 2013A Redeemable Institutional Preferred Shares specified in the Put Notice or the Call Notice, as the case may be, and the Corporation shall pay the Put Price or the Call Price (as such terms are defined in subsection
(iv) of this subsection (g) below), as the case may be, to such holder. At the closing (hereinafter referred to in this subsection (g) as the “Closing”) of the purchase and sale of the 2013A Redeemable Institutional
Preferred Shares pursuant to this subsection (g), the selling holder of the 2013A Redeemable Institutional Preferred Shares shall deliver to the Corporation such instruments and documents as shall be necessary or appropriate to transfer the 2013A
Redeemable Institutional Preferred Shares being sold by such holder to the Corporation, and the Corporation shall purchase and accept such 2013A Redeemable Institutional Preferred Shares and shall pay the Put Price or the Call Price, as the case may
be, to such holder by wire transfer of immediately available funds to the account of such holder provided in writing by such holder to the Corporation. At the Closing, the selling holder of 2013A Redeemable Institutional Preferred Shares shall
provide the Corporation with a certificate, executed on behalf of such holder by an authorized officer thereof, to the effect that such holder has good and valid title to the 2013A Redeemable Institutional Preferred Shares being sold, free and clear
of all liens, other than restrictions on transfer pursuant to these Amended and Restated Articles of Incorporation and the Corporation’s Amended and Restated Code of Regulations. 

(iv) For purposes of this subsection (g): 
 (A) The “Put Price” for each 2013A Redeemable Institutional Preferred Share being purchased by the Corporation shall be (1) in the event that the Put Price Calculation Date (as defined
below) is on or prior to January 31, 2018 (hereinafter referred to in this subsection (g) as the “Price Adjustment Date”), an amount equal to 95% of the Adjusted Book Value per 2013A Redeemable Institutional Preferred Share, plus
all accrued but unpaid dividends on each 2013A Redeemable Institutional Preferred Share or (2) in the event that the Put Price Calculation Date is after the Price Adjustment Date, an amount equal to 100% of the Adjusted Book Value per 2013A
Redeemable Institutional Preferred Share, plus all accrued but unpaid dividends on each 2013A Redeemable Institutional Preferred Share. 
 (B) The “Put Price Calculation Date” shall be the last day of the month immediately preceding the date of the Corporation’s receipt of a Put Notice. 

  
 - 6 -

 (C) The “Call Price” for each 2013A Redeemable Institutional Preferred Share
being purchased by the Corporation shall be (1) in the event that the Call Price Calculation Date (as defined below) is prior to the Price Adjustment Date, an amount equal to the greater of (x) 105% of the Adjusted Book Value per 2013A
Redeemable Institutional Preferred Share and (y) the 2013A Issue Price, in each case plus all accrued but unpaid dividends on each 2013A Redeemable Institutional Preferred Share, or (2) in the event that the Call Price Calculation Date is
on or after the Price Adjustment Date, an amount equal to 100% of the Adjusted Book Value per 2013A Redeemable Institutional Preferred Share, plus all accrued but unpaid dividends on each 2013A Redeemable Institutional Preferred Share. 

(D) The “Call Price Calculation Date” shall be the last day of the month immediately preceding the date of a holder’s
receipt of a Call Notice. 
 (v) Notwithstanding anything to the contrary contained in this subsection (g), if a Liquidation
Event (as defined in subsection (h) of this subsection 9 below) occurs within 90 days of a Closing of the purchase of all or any portion of the 2013A Redeemable Institutional Preferred Shares in connection with the exercise of a Call Right by
the Corporation, then the holder of the 2013A Redeemable Institutional Preferred Shares so purchased by the Corporation pursuant to the Call Right shall be entitled to an additional cash payment in an amount equal to the difference, if positive,
between the Estimated Cash Payment (as defined in subsection (h) of this subsection 9 below) and the Call Price. 
 (h)
PAYMENT UPON A LIQUIDATION EVENT. 
 (i) Notwithstanding Section B.4 of this Article FOURTH, in the event of any liquidation,
dissolution or winding up of the Corporation, any merger or consolidation involving the Corporation (other than one in which shareholders of the Corporation own a majority by voting power of the outstanding shares of the surviving or acquiring
corporation), or any sale, lease, transfer or other disposition of all or substantially all of the assets of the Corporation (each of the foregoing, a “Liquidation Event” for purposes of this subsection 9), the holders of the 2013A
Redeemable Institutional Preferred Shares shall receive, in redemption of the 2013A Redeemable Institutional Preferred Shares, a cash payment equal to the greater of: 
 (A) 100% of the Adjusted Book Value per 2013A Redeemable Institutional Preferred Share, plus all accrued but unpaid dividends on each 2013A Redeemable Institutional Preferred Share, and such payment shall
be equal to the rights to any payments to the holders of other Preferred Shares, including the 2012A Redeemable Institutional Preferred Shares, the 2010 Redeemable Institutional Preferred Shares and the Provider Preferred Shares, and shall be senior
to any right of payment to the holders of the Common Shares and the Common Shares shall rank junior to the 2013A Redeemable Institutional Preferred Shares; or 
 (B) the Estimated Cash Payment (as defined below). 
 (ii) For purposes of this
subsection 9, the “Estimated Cash Payment” shall be computed as follows: 

  
 - 7 -

 (A) If the Consideration (as defined below in this subsection 9) is paid, payable or
contributed directly to the holders of the Common Shares in connection with a Liquidation Event, an amount equal to (1) the per Common Share Consideration (as defined and described in clause (b) of subsection (h)(ii)(C)(2) below of this
subsection 9) paid, payable or contributed to the holders of the Common Shares, times (2) the number of Class B Common Shares that would be issued if the 2013A Redeemable Institutional Preferred Shares were converted, on a hypothetical basis,
at the Conversion Ratio (as defined below in this subsection 9). 
 (B) For all other Liquidation Events not covered by
subsection (h)(ii)(A) above of this subsection 9, the Enterprise Value (as defined below in this subsection 9) shall be divided by the total number of Common Share Equivalents (as defined below in this subsection 9), and the resulting quotient shall
be the Estimated Cash Payment per 2013A Redeemable Institutional Preferred Share. 
 (C) For purposes of computing the Estimated
Cash Payment: 
 (1) “Enterprise Value” means an amount equal to the aggregate Consideration (as defined in clause
(a) of subsection (h)(ii)(C)(2) below of this subsection 9) paid, payable or contributed, directly or indirectly, by an acquiror to the Corporation in connection with a Liquidation Event, reduced by the Aggregate Reduction Amount (as defined
below in this subsection 9). 
 (2) “Consideration” means (a) the total value of all cash, securities (including
any debt or equity securities, options or warrants, collectively, “Securities”), agreements with the Corporation or any of its subsidiaries (including, but not limited to, consulting agreements, agreements not to compete and similar
agreements) and other property or non-cash consideration paid, payable or contributed, directly or indirectly, by an acquiror to the Corporation in connection with a Liquidation Event and any contingent, escrowed or earned amounts (calculated at the
present value of such amounts as of the date on which the Liquidation Event is consummated) or (b) the per Common Share value of all cash and Securities paid, payable or contributed directly by an acquiror to the holders of the Common Shares in
connection with a Liquidation Event and any contingent, escrowed or earned amounts. For purposes of this subsection (h), the value of (x) all freely tradeable Securities for which a public trading market exists as of the date on which the
Liquidation Event is consummated will equal the last closing market price of such Securities on the business day prior to public announcement of the Liquidation Event, (y) all Securities which are not freely tradeable or which have no
established public market will equal the fair market value thereof as determined by the Corporation and the holder of the 2013A Redeemable Institutional Preferred Shares and (z) all other property or non-cash consideration will equal the face
value thereof or other appropriate value as determined by the Corporation and the holder of the 2013A Redeemable Institutional Preferred Shares. With respect to clauses (y) and (z) above, in the event the Corporation and the holders of the
2013A Redeemable Institutional Preferred Shares cannot agree on such value within 30 days, then they shall select an independent accounting firm reasonably acceptable to all parties, and such accounting shall conclusively establish such value. If
the Consideration is computed or payable in foreign currency, the value of such foreign currency will, for purposes 

  
 - 8 -

 
hereof, be converted into U.S. dollars at the noon buying rate in New York City on the date or dates on which such Consideration is payable. 

(3) “Aggregate Reduction Amount” means an amount equal to the sum of (x) the aggregate amount payable by the Corporation
as a liquidation preference to holders of the 2012A Redeemable Institutional Preferred Shares (pursuant to subsection 8(h) of Section B of this Article FOURTH), the 2010 Redeemable Institutional Preferred Shares (pursuant to subsection 7(h) of
Section B of this Article FOURTH), the Provider Preferred Shares (pursuant to subsection 6(h) of Section B of this Article FOURTH), and any other liquidation preference for senior securities, plus (y) an amount equal to the
Corporation’s liabilities on a consolidated basis (as set forth on the Corporation’s then-most recent balance sheet) but only to the extent such liabilities cannot be satisfied by the Corporation’s assets or are not otherwise assumed
by the acquiror (directly or by operation of law) in connection with the Liquidation Event, plus (z) the aggregate amount of all transaction expenses, including accounting, legal, and investment advisory fees and expenses, incurred by
the Corporation as a result of or in connection with the Liquidation Event. 
 (4) “Common Share Equivalents” shall
include (a) all issued and outstanding Common Shares, (b) all securities convertible into or settled based upon a class of Common Shares, including any and all stock options, warrants, restricted shares, restricted share units and phantom
shares, (c) the number of Class B Common Shares that would be issued if the 2012A Redeemable Institutional Preferred Shares were converted, on a hypothetical basis, at the Conversion Ratio (as defined in subsection 8(h) of Section B of this
Article FOURTH) and (d) the number of Class B Common Shares that would be issued if the 2013A Redeemable Institutional Preferred Shares were converted, on a hypothetical basis, at the Conversion Ratio (as defined below in this subsection 9).

 (5) “Conversion Ratio” means one 2013A Redeemable Institutional Preferred Share to 1.2 Class B Common Shares
(1:1.2). 
 [Signature appears on the following page.] 

  
 - 9 -

 IN WITNESS WHEREOF, the undersigned has executed this instrument as of January 9, 2013.

  

	
	/s/ Fred J. Bronson, DDS
	Fred J. Bronson, DDS
	Secretary

  
 - 10 -Agreement and Release

 Exhibit 10.1 
 January 10, 2013 
 John Nugent 

							
				
	  
	 		 		 	
				
	  
	 		 		 	

 Dear John: 

This letter (this “Agreement and Release”), upon your signature, confirms the entire agreement between Serena Software, Inc.
(“Serena”) and you regarding the terms of your separation from employment with Serena. 
 1) You and Serena hereby agree that
your employment, and any and all appointments that you hold with Serena, whether as a director, officer, employee, agent or otherwise, are terminated as of January 10, 2013 (the “Separation Date”). Effective as of the
Separation Date, you hereby resign as a director of Serena’s board of directors and as President and Chief Executive Officer of Serena. Effective as of the Separation Date, you shall have no authority to act on behalf of Serena, and shall not
hold yourself out as having such authority or otherwise act in a board or executive or other decision making capacity. Regardless of whether you sign this Agreement and Release, Serena will do the following: 

a. Pay you all earned salary and accrued vacation (adjusted for any vacation days taken by you but not reflected in Serena’s payroll
records) through the Separation Date. 
 b. Continue your medical, dental and vision benefits through January 31, 2013 in
accordance with the terms of Serena’s group health coverage benefit plans. You will have the option to continue your medical, dental and vision benefits under the Consolidated Budget Omnibus Reconciliation Act of 1985, as amended
(“COBRA”). COBRA continuation forms will be sent to you by our third-party administrator. 
 c. Discontinue
your insurance coverage for life, accidental death & dismemberment, and disability coverage and your participation in all of Serena’s other benefit plans and programs effective upon the Separation Date. However, you will have the
option of converting your life insurance to a private plan. Serena’s Human Resources Department will provide you with life insurance conversion forms and instructions. 

 John Nugent 
 January 10, 2013 
  

 2) Subject to your execution, delivery and non-revocation of this Agreement and Release (including with
respect to the General Release granted herein) pursuant to Section 18 below and subject to the continued effectiveness of this Agreement and Release and, with respect to item b. below, your continued observation and performance of your ongoing
obligations to Serena and its affiliates under Sections 8 through 10 below: 
 a. Serena will pay you, as severance pay, a lump
sum amount equal to $137,500, which represents an amount equal to 25% of your annual base salary, on the first most practicable payroll date to occur after the Release Effective Date (as defined below). The foregoing severance payment will be less
applicable payroll taxes and tax withholdings and made in accordance with Serena’s usual and customary payroll practices. 

b. Subject to (i) your timely election of continuation coverage under COBRA, and (ii) your continued co-payment of premiums in
the same amount as you paid immediately prior to termination, continued participation (to the extent permitted under applicable law and the terms of such plan) for you and your then-eligible dependents in Serena’s group health plan in which you
(and they) were participating upon the Separation Date for up to a twelve-month period commencing on February 1, 2013, at Serena’s expense. You agree to immediately notify Serena of the date that you become covered under another group
health plan, and your COBRA continuation under Serena’s group health benefit plans will be terminated as of such date. 
 3) On behalf of
yourself, your agents and assigns, in consideration for Serena’s obligations under Section 2 of this Agreement and Release, you hereby waive and release any and all claims, whether known or unknown, that you have against Serena and its
predecessors, subsidiaries, affiliates and related entities and their respective officers, directors, shareholders, agents, attorneys, employees, successors, or assigns, arising from or out of your employment with and/or the termination of your
employment with Serena. These claims include, but are not limited to, claims arising under: Title VII of the Civil Rights Act of 1964, as amended; The Employee Retirement Income Security Act of 1974, as amended; The Americans with Disabilities Act
of 1990, as amended; The Age Discrimination in Employment Act of 1967, as amended (“ADEA”); The Workers Adjustment and Retraining Notification Act, as amended; The California Fair Employment and Housing Act, as amended; The
California Family Rights Act, as amended; any other federal, state or local discrimination, harassment, civil or human rights law or any other local, state or federal law, regulation or ordinance; any public policy, contract, tort, or common law;
any Serena compensation or benefit plan under which you were eligible, except as expressly provided herein; any stock options granted to you during your employment with Serena, except as expressly provided herein; and any claim for costs, fees, or
other expenses including attorneys’ fees incurred by you in connection with such matters. Nothing herein is intended to release any claim that is unwaivable by law or governmental regulation, or any obligation of Serena under this Agreement and
Release. 
 4) You also acknowledge that there may exist claims or facts in addition to or different from those which are now known or believed
by you to exist and agree that it is your intention to fully settle and release such claims, whether known or unknown, that may exist as of the time you sign this Agreement and Release. You therefore waive your rights under Section 1542 of the
Civil Code of California, which states: 
 A general release does not extend to claims which the creditor does not know or
suspect to exist in his or her favor at the time of executing the release, which if known to him or her must have materially affected his or her settlement with the debtor. 

  
 Page 2 of 8

 John Nugent 
 January 10, 2013 
  

 You acknowledge that you have read this Agreement and Release, including the waiver of California Civil
Code Section 1542, and understand you may later discover facts different from or in addition to those known or now believed to be true with respect to the matters released or described in this Agreement and Release. You agree that the release
and agreements contained in this Agreement and Release shall be and will remain effective in all respects notwithstanding any later discovery of any such different or additional facts. 
 5) You affirm that you have been paid and have received all leave (paid and unpaid), compensation, salary, wages, bonuses, commissions and/or benefits to which you may be entitled and that no other leave
(paid or unpaid), compensation, salary, wages, bonuses, commissions and any benefits are due to you, except as provided in this Agreement and Release. Serena will reimburse you for reasonable and customary business expenses incurred prior to the
Separation Date pursuant to the terms of Serena’s Business Expense Policy, provided that you submit a completed expense reimbursement form and supporting documentation no later than fifteen (15) days following the Separation Date. You
further affirm that you have no known workplace injuries or occupational diseases, other than any injuries or diseases that have been previously reported. 
 6) You agree that all stock options granted to you under the 2006 Stock Option Plan, as amended (the “2006 Plan”) that vested on or prior to the Separation Date in accordance with the
terms of the applicable option agreement will remain exercisable until April 10, 2013; thereafter, such options will terminate automatically and will not be exercisable in accordance with the terms of the 2006 Plan. All stock options granted to
you under the 2006 Plan that have not vested on or prior to the Separation Date and all restricted stock units granted to you under the 2006 Plan will be cancelled as of the Separation Date. A schedule of all outstanding stock options granted to you
under the 2006 Plan that are vested as of your Separation Date is set forth on Exhibit A attached hereto. You will retain ownership of the 230,320 shares of common stock that were issued to you in connection with the vesting of your
restricted stock units on November 15, 2012, subject to the terms of the Management Stockholders Agreement dated March 7, 2006 and which will be held by Serena in escrow pursuant to the terms of the Joint Escrow Instructions dated
November 5, 2012. 
 7) You agree that you will return to Serena on or before the Separation Date all Serena property within your
possession, custody or control, including any equipment (including, without limitation, your cellular phone, PDA, laptop computer and other equipment) and any confidential and proprietary information (including, without limitation, customer lists,
customer licensing and support information, sales and forecast information, operating plan and budget information, employee lists and organizational charts, board presentations, etc.), whether in hardcopy or electronic form; and keys and access
badges. Notwithstanding the preceding to the contrary, you may retain the cellular phone that was either issued to you and/or for which you were reimbursed by Serena, provided that you delete all Confidential Information from the cell phone on your
Separation Date. If the cellular service for your cell phone is provided under a corporate account maintained by Serena, your cellular service will be terminated within three (3) days following your Separation Date. 

  
 Page 3 of 8

 John Nugent 
 January 10, 2013 
  

 8) To the fullest extent permitted by law, at no time subsequent to the execution of this Agreement and
Release will you pursue, or cause or knowingly permit the prosecution, in any state, federal or foreign court, or before any local, state, federal or foreign administrative agency, or any other tribunal, any charge, claim or action of any kind,
nature and character whatsoever, known or unknown, which you may now have, have ever had, or may in the future have against Serena and/or any officer, director, employee, agent or shareholder of Serena, which is based in whole or in part on any
claim covered under Section 3 of this Agreement and Release. Nothing in this Section 8 shall preclude you from (i) enforcing this Agreement and Release or exercising any rights that you may have that have not been waived under the
terms of this Agreement and Release; (ii) initiating or causing to be initiated on your behalf any complaint, charge, claim or proceeding against Serena before any local, state or federal agency, court or other body challenging the validity of
the waiver of your claims under ADEA contained in Section 3 (but no other portion of such waiver); or (iii) initiating or participating in (but not benefiting from) an investigation or proceeding conducted by the Equal Employment
Opportunity Commission with respect to ADEA. 
 9) You agree to continue to abide by the terms of the Agreement Regarding Confidential
Information and Assignment of Inventions between you and Serena (“Confidentiality Agreement”), including, without limitation, your obligations regarding Confidential Information under Article I and your obligations regarding
Inventions under Article II, but excluding your obligations regarding non-competition and non-solicitation under Article III. The foregoing terms of your Confidentiality Agreement are incorporated herein, and all defined terms used in this
Section 9 shall have the same meanings as set forth in the Confidentiality Agreement. 
 10) You agree to refrain from making any adverse,
derogatory or disparaging statements or comments, either as fact or opinion, about Serena and its subsidiaries, affiliates and related entities; management; practices; operations; performance; products; past or present directors, officers, employees
or shareholders; and any similar information concerning Serena. In addition, you agree to refrain from any tortious interference with contracts, relationships and prospective economic advantage of Serena. You agree that any breach of this covenant
would irreparably injure Serena, and Serena shall have the right to obtain an injunction against you from a court of competent jurisdiction restraining you from any further breach of this covenant. Nothing in this Section 10 shall prohibit you
from providing truthful information in response to a subpoena or other legal process, provided that you provide Serena with prompt prior written notice of the required disclosure and an opportunity to seek a protective order or other appropriate
remedy. Serena agrees to refrain from making any defamatory, libelous or slanderous statements about you or your employment with Serena, and you will have the right to obtain an injunction against Serena from a court of competent jurisdiction
restraining Serena from any further breach of this covenant. 
 11) In consideration for the payment of an amount equal to $412,500, which
represents an amount equal to 75% of your annual base salary, over a period of twelve (12) months (the 

  
 Page 4 of 8

 John Nugent 
 January 10, 2013 
  

 
“Restrictive Covenant Payment”), payable in equal installments on a semi-monthly basis in accordance with Serena’s usual and customary payroll practices and less applicable
payroll taxes and tax withholdings, you hereby agree that, during the twelve (12) month period following the Separation Date, you will not (i) perform any function or service, whether as a director, officer, employee, consultant, agent,
advisor or otherwise, for any entity that is a Competing Business and (ii) whether on your own behalf or on behalf of or in conjunction with any other person, directly or indirectly, hire any person who is an employee of Serena and its
subsidiaries. The Restrictive Covenant Payment shall commence on the first payroll date to occur after the Release Effective Date. In the event that Serena determines that you have breached this Section 11, Serena shall immediately cease and
permanently discontinue any further installments of the Restrictive Covenant Payment. As used herein, a “Competing Business” is any entity (or division or business unit of an entity) that is substantially in the business of
developing, marketing, selling or providing software (whether on premises or software-as-a-service) or services for application lifecycle management or IT service management, including, without limitation, ASG Software Solutions, BMC Software, CA
Technologies (previously known as CA and Computer Associates), Compuware, IBM’s Rational and Tivoli software divisions, Hewlett-Packard’s software division, MicroFocus, Nolio and ServiceNow. 

12) Except with regard to Sections 8 through 10 above, you agree that any dispute applicable to this Agreement and Release shall be submitted to and
resolved through binding arbitration pursuant to the terms of the Binding Arbitration Agreement between you and Serena. 
 13) This Agreement
and Release sets forth the entire agreement between the parties hereto, and fully supersedes any prior agreements or understandings between the parties, except the Confidentiality Agreement, the Binding Arbitration Agreement and any benefit plans
applicable to COBRA continuation. Notwithstanding the preceding to the contrary, Article III of your Confidentiality Agreement is hereby terminated. This Agreement and Release shall terminate and fully extinguish any and all rights that you may have
under the Employment Agreement. You acknowledge that you have not relied on any representations, promises, or agreements of any kind made to you in connection with your decision to accept this Agreement and Release, except for those set forth in
this Agreement and Release. 
 14) This Agreement and Release shall be governed and conformed in accordance with the laws of the state of
California without regard to its conflict of laws provisions. 
 15) This Agreement and Release may not be modified, altered or changed except
upon express written consent of both Serena and you wherein specific reference is made to this Agreement and Release. 
 16) Should any of the
provisions of this Agreement and Release be determined to be invalid by a court, arbitrator, or government agency of competent jurisdiction, it is agreed that such determination shall not affect the enforceability of the other provisions herein.
Specifically, should a court, arbitrator, or agency conclude that a particular claim may not be released or a restrictive covenant may not be enforced as a matter of law, it is the intention of the parties that the general release, the waiver of
unknown claims, and the covenant not to sue shall otherwise remain effective to release any and all other claims covered thereby. 

  
 Page 5 of 8

 John Nugent 
 January 10, 2013 
  

 17) You have up to twenty-one (21) days from the date of your receipt of this letter to accept the
terms of this Agreement and Release, although you may accept it at any time within those twenty-one (21) days. You are advised to consult an attorney about whether or not to sign this Agreement and Release. 

18) To accept this Agreement and Release, please sign and date this letter and return it to me no later than the twenty-one
(21) day period referred to in Section 17 above. Once you do so, you will have an additional seven (7) days in which to revoke your acceptance. To revoke, you must deliver to me a written statement of revocation no later than seven
(7) days after you execute this Agreement and Release. If you do not submit your revocation to me, then the eighth
(8th) day after your execution of this Agreement and
Release will be the “Release Effective Date” of this Agreement and Release. If the last day of the revocation period is a Saturday, Sunday, or legal holiday in the state in which you were employed at the time of your last day of
employment, then the revocation period shall not expire until the next following day which is not a Saturday, Sunday, or legal holiday. If you revoke this Agreement and Release, you will have no right or entitlement to any of the payments or
benefits described in this Agreement and Release (except as described in Section 1). You will not be entitled to receive any of the payments or benefits provided in any Section of this Agreement and Release, other than Section 1, until the
occurrence of the Release Effective Date. You hereby acknowledge and agree that you have been provided with a copy of this Agreement and Release on or prior to the Separation Date and understand that this Agreement and Release must become effective
prior to the expiration of the acceptance and revocation periods described above in order for you to be entitled to the severance payments and benefits described in Section 2. 
 19) This Agreement and Release may be executed by one or more of the parties hereto on any number of separate counterparts and all such counterparts shall be deemed to be one and the same instrument. Each
party hereto confirms that any facsimile or PDF copy of such party’s executed counterpart of this Agreement and Release (or its signature page thereof) shall be deemed to be an executed original thereof. 

  
 Page 6 of 8

 John Nugent 
 January 10, 2013 
  

 I wish you success in your future and professional efforts. 

Sincerely, 
 /s/ Edward Malysz 

Edward Malysz 
 Senior Vice President, General
Counsel 
 Acknowledgement and Acceptance: 
 By signing this Agreement and Release, I acknowledge that I have been advised to review this Agreement and Release with an attorney before signing it, and have had the opportunity to review this Agreement
and Release with an attorney of my choice, or have done or voluntarily chosen not to do so; that I have read and fully understand the terms of the Agreement and Release; and that I hereby voluntarily agree to them. 

 

							
	Dated: 1/10/13	  	Signed:	  	 /s/ John Nugent
	  	

*            *          
  * 

  
 Page 7 of 8

 Exhibit A 

Schedule of Vested Stock Options as of the Separation Date 

 

											
	 Grant Date
	  	 Plan
	  	 Type
	  	 Exercise Price
	 	  	 Vested and
Exercisable as of the

Separation Date

	 11/15/2009
	  	2006 Plan	  	Time	  	$	3.00	  	  	875,000
	 11/15/2009
	  	2006 Plan	  	Performance	  	$	3.00	  	  	232,131

 Note: All vested stock options granted under 2006 Stock Incentive Plan will remain exercisable for a period of three
(3) months following the Separation Date; thereafter, the stock options will automatically terminate.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]